Références
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74
Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92
Passot G, Bakrin N, Isaac S, et al (2014) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 40:957–62
Sommariva A, Zagonel V, Rossi CR (2012) The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 19:3737–44
Allard MA, Adam R, Ruiz A, et al (2013) Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol 39:981–7
Maggiori L, Goere D, Viana B, et al (2013) Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg 258:116–21
Honore C, Goere D, Souadka A, et al (2013) Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 20:183–92
Verwaal VJ, Bruin S, Boot H, et al (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32
Verwaal VJ, van Ruth S, de Bree E, et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–43
Elias D, Lefevre JH, Chevalier J, et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5
Desolneux G, Maziere C, Vara J, et al (2015) Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only. PloS One 10:e0122816
Matsuda K, Hotta T, Takifuji K, et al (2012) Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis. Surgery 151:238–44
Goere D, Malka D, Tzanis D, et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:1065–71
Faron M, Macovei R, Goere D, et al (2015) Linear relationship of Peritoneal Cancer Index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol [Epub ahead of print]
Glehen O, Gilly FN, Boutitie F, et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–18
Elias D, Gilly F, Boutitie F, et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric french study. J Clin Oncol 28:63–8
Elias D, Honore C, Dumont F, et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289–93
Hompes D, Aalbers A, Boot H, et al (2014) A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer. Colorectal Dis 16:264–72
Klaver YL, Lemmens VE, Creemers GJ, et al (2011) Populationbased survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 22:2250–6
Klaver YL, Simkens LH, Lemmens VE, et al (2012) Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 38:617–23
Passot G, You B, Boschetti G, et al (2014) Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol 21:2608–14
Maillet M GO, Lambert, Goere D, et al Early post-operative chemotherapy after complete cytoreduction and hyperthermic intra peritoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study. underreview Journée nationale des carcinoses péritonéales, Paris 2015
Klaver YL, de Hingh IH, Boot H, et al (2011) Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy. J Surg Oncol 103:431–4
Passot G, Vaudoyer D, Cotte E, et al (2012) Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 256:125–9
Spiliotis J, Efstathiou E, Halkia E, et al (2012) The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome. Hepatogastroenterology 59:705–8
Sugarbaker PH (1996) Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res 82:79–100
Goere D, Allard MA, Honoré C, et al (2013) Incidence and prognosis of synchronous colorectal carcinomatosis. Fut Oncol 9:541–9
Segelman J, Granath F, Holm T, et al (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99:699–705
Jayne DG, Fook S, Loi C, et al (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–50
Verwaal VJ, Bruin S, Boot H, et al (2008) 8-Year Follow-up of Randomized Trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32
Elias D, Lefèvre JH, Chevalier J, et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5
Elias D, Goere D, Blot F, et al (2007) Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 °C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14:1818–24
Honoré C, Goere D, Souadka A, et al (2012) Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 20:183–92
Elias D, Goere D, Di Pietrantonio D, et al (2008) Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247:445–50
Elias D, Honore C, Dumont F, et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289–93
Matsuda K, Hotta T, Takifuji K, et al (2012) Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis. Surgery 151:238–44
Mulsow J, Merkel S, Agaimy A, et al (2011) Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg 98:1785–91
Glehen O, Gilly FN, Boutitie F, et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Cancer 116:5608–18
Pestieau SR, Sugarbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 43:1341–6; discussion 1347–8
Glehen O (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–92
Braam HJ, Boerma D, Wiezer MJ, et al (2013) Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment. Eur J Surg Oncol 39:988–93
Allard MA, Adam R, Ruiz A, et al (2013) Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol 39:981–7
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Passot, G., Glehen, O., Sourrouille, I. et al. Controverse. Colon Rectum 9, 230–234 (2015). https://doi.org/10.1007/s11725-015-0601-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11725-015-0601-7